Seelos Therapeutics, Inc.
NASDAQ:SEEL
1.03 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2.203 | 0 | 0 | 0 | 0.375 | 0 | 0 | 5.763 | 4.839 | 9.259 | 2.511 | 8.416 | 4.101 | 4.973 | 2.974 | 5.957 | 1.27 | 1.867 | 2.399 | 0.359 | 0.111 | 0.148 | 0.068 | 0 | 1.5 | 5.709 | 0.056 |
| Cost of Revenue
| 0.057 | 0.053 | 0 | 0 | 22.563 | 0 | 0.117 | 3.891 | 0.922 | 0.918 | 2.631 | 4.554 | 2.237 | 3.943 | 0.128 | 0 | 0 | 0 | 0 | 0 | 0 | 0.027 | 0.045 | -0.257 | 1.3 | 5.186 | 0 |
| Gross Profit
| 2.146 | -0.053 | 0 | 0 | -22.188 | 0 | -0.117 | 1.872 | 3.917 | 8.341 | -0.12 | 3.862 | 1.864 | 1.03 | 2.845 | 5.957 | 1.27 | 1.867 | 2.399 | 0.359 | 0.111 | 0.121 | 0.023 | 0.257 | 0.2 | 0.523 | 0.056 |
| Gross Profit Ratio
| 0.974 | 0 | 0 | 0 | -59.168 | 0 | 0 | 0.325 | 0.809 | 0.901 | -0.048 | 0.459 | 0.455 | 0.207 | 0.957 | 1 | 1 | 1 | 1 | 1 | 1 | 0.817 | 0.338 | 257,150 | 0.133 | 0.092 | 1 |
| Reseach & Development Expenses
| 30.117 | 58.62 | 46.649 | 10.984 | 22.563 | 1.22 | 3.463 | 6.831 | 14.649 | 21.288 | 5.123 | 5.375 | 5.821 | 2.11 | 1.883 | 5.411 | 5.023 | 5.425 | 11.222 | 10.684 | 8.439 | 21.616 | 12.456 | 6.892 | 2.4 | 2.302 | 2.079 |
| General & Administrative Expenses
| 12.585 | 12.296 | 15.02 | 7.775 | 7.559 | 7.928 | 7.21 | 8.434 | 10.516 | 11.418 | 13.554 | 15.377 | 11.463 | 10.152 | 4.196 | 5.721 | 5.634 | 5.571 | 6.878 | 6.98 | 5.901 | 6.065 | 4.77 | 3.209 | 1.8 | 2.635 | 1.825 |
| Selling & Marketing Expenses
| -0.057 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 12.528 | 12.296 | 15.02 | 7.775 | 7.559 | 7.928 | 7.21 | 8.434 | 10.516 | 11.418 | 13.554 | 15.377 | 11.463 | 10.152 | 4.196 | 5.721 | 5.634 | 5.571 | 6.878 | 6.98 | 5.901 | 6.065 | 4.77 | 3.209 | 1.8 | 2.635 | 1.825 |
| Other Expenses
| -30.117 | -3.017 | 0.23 | 0 | -0.375 | 0.001 | 0.077 | -0.022 | -0.064 | 0.082 | -0.376 | 0.175 | 2.76 | 10.168 | 457.023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.257 | 0.1 | 0 | 0 |
| Operating Expenses
| 42.645 | 70.916 | 61.669 | 18.759 | 29.747 | 9.148 | 10.673 | 15.265 | 25.165 | 30.9 | 18.677 | 20.752 | 20.044 | 22.431 | 6.08 | 11.131 | 10.657 | 10.996 | 18.1 | 17.664 | 14.34 | 27.681 | 17.226 | 10.359 | 4.3 | 4.937 | 3.903 |
| Operating Income
| -40.499 | -70.916 | -61.669 | -18.759 | -29.747 | -9.148 | -10.675 | -13.407 | -21.35 | -22.559 | -17.367 | -24.894 | -18.18 | -21.401 | -3.82 | -5.174 | -9.387 | -9.129 | -15.701 | -17.305 | -14.229 | -27.56 | -17.203 | -10.102 | -4.1 | -4.414 | -3.847 |
| Operating Income Ratio
| -18.384 | 0 | 0 | 0 | -79.325 | 0 | 0 | -2.326 | -4.412 | -2.436 | -6.916 | -2.958 | -4.433 | -4.304 | -1.285 | -0.868 | -7.389 | -4.89 | -6.544 | -48.153 | -128.488 | -186.182 | -252.66 | -10,101,747 | -2.733 | -0.773 | -68.486 |
| Total Other Income Expenses Net
| 2.617 | -2.618 | -4.379 | -0.342 | -21.133 | -0.07 | -0.993 | 7.443 | 3.07 | 0.082 | 3.654 | -7.829 | 0.426 | 0.715 | -0.575 | -0.935 | -0.206 | 0.627 | -0.222 | 0.082 | -0.153 | -0.081 | -0.175 | 0.126 | 1.8 | 0 | 0 |
| Income Before Tax
| -37.882 | -73.534 | -66.048 | -19.101 | -50.88 | -9.218 | -11.749 | -7.433 | -19.023 | -22.477 | -15.87 | -25.044 | -18.117 | -29.508 | -32.48 | -6.109 | -9.593 | -8.611 | -15.924 | -17.563 | -17.466 | -27.884 | -17.378 | -9.976 | -2.3 | 0 | 0 |
| Income Before Tax Ratio
| -17.196 | 0 | 0 | 0 | -135.68 | 0 | 0 | -1.29 | -3.931 | -2.428 | -6.32 | -2.976 | -4.418 | -5.934 | -10.923 | -1.025 | -7.551 | -4.612 | -6.637 | -48.871 | -157.715 | -188.371 | -255.227 | -9,976,002 | -1.533 | 0 | 0 |
| Income Tax Expense
| -0.111 | 2.604 | 1.485 | 0.119 | -0.497 | -0.07 | -11.91 | 1 | 0.781 | -0.691 | 1.068 | 0.516 | 0.377 | 18.029 | -0.438 | -0.938 | -0.806 | -0.567 | -0.481 | -0.539 | -0.232 | -0.243 | -1.029 | -1.272 | -1.6 | 0.365 | 0.01 |
| Net Income
| -37.882 | -76.138 | -67.533 | -19.22 | -50.383 | -9.242 | 0.321 | -7.433 | -19.023 | -21.786 | -16.938 | -31.771 | -18.117 | -29.508 | -32.043 | -5.171 | -8.787 | -8.043 | -15.442 | -17.024 | -17.234 | -27.642 | -16.175 | -8.83 | -2.5 | -4.779 | -3.857 |
| Net Income Ratio
| -17.196 | 0 | 0 | 0 | -134.355 | 0 | 0 | -1.29 | -3.931 | -2.353 | -6.746 | -3.775 | -4.418 | -5.934 | -10.775 | -0.868 | -6.917 | -4.308 | -6.437 | -47.371 | -155.62 | -186.732 | -237.555 | -8,830,071 | -1.667 | -0.837 | -68.669 |
| EPS
| -7.73 | -21.48 | -22.29 | -12.88 | -74.43 | -89.97 | 24.32 | -67.41 | -3,442.83 | -165 | -147.66 | -347.13 | -271.44 | -747.22 | -1,627.6 | -278.08 | -482.15 | -547.23 | -1,323.03 | -1,757.01 | -2,304.92 | -4,617.69 | -2,856.24 | -1,817.26 | -819.94 | -2,880.65 | -2,857.38 |
| EPS Diluted
| -7.73 | -21.48 | -22.29 | -12.88 | -74.43 | -89.97 | 24.32 | -67.41 | -3,442.83 | -165 | -147.66 | -347.13 | -271.44 | -747.22 | -1,627.6 | -278.08 | -482.15 | -547.23 | -1,323.03 | -1,757.01 | -2,304.92 | -4,617.69 | -2,856.24 | -1,817.26 | -819.94 | -2,880.65 | -2,857.38 |
| EBITDA
| -40.442 | -73.759 | -61.326 | -18.714 | -29.33 | -9.106 | -10.479 | -13.587 | -21.012 | -22.559 | -19.096 | -16.512 | -17.564 | -11.205 | -2.821 | -4.616 | -8.356 | -8.586 | -14.433 | -16.391 | -12.826 | -26.413 | -16.502 | -9.97 | -5.8 | -4.073 | -3.816 |
| EBITDA Ratio
| -18.358 | 0 | 0 | 0 | -78.213 | 0 | 0 | -2.358 | -4.342 | -2.436 | -7.605 | -1.962 | -4.283 | -2.253 | -0.949 | -0.775 | -6.578 | -4.599 | -6.016 | -45.611 | -115.814 | -178.43 | -242.353 | -9,970,343 | -3.867 | -0.713 | -67.922 |